Table 4

Adjusted HRs* of hospitalised myocardial infarction and ischaemic stroke among patients with rheumatoid arthritis (eight separate models)

MIStroke
CRP (mg/L)
 <1ReferenceReference
 1–21.19 (0.56 to 2.55)1.03 (0.43 to 2.46)
 3–101.72 (0.85 to 3.48)1.37 (0.62 to 3.06)
 >102.12 (1.02 to 4.38)1.76 (0.77 to 4.03)
ESR (mm/h)
 <14ReferenceReference
 14–271.48 (0.90 to 2.45)1.46 (0.81 to 2.62)
 28–421.20 (0.59 to 2.43)1.29 (0.58 to 2.86)
 >422.53 (1.48 to 4.31)2.51 (1.33 to 4.75)
HDL-cholesterol (mg/dL/mmol/L)
 <40/1.0ReferenceReference
 40/1.0–49/1.30.68 (0.44 to 1.05)0.78 (0.43 to 1.42)
 50/1.3–59/1.50.40 (0.24 to 0.70)0.57 (0.28 to 1.15)
 ≥60/1.60.37 (0.21 to 0.66)0.48 (0.22 to 1.01)
LDL-cholesterol (mg/dL/mmol/L)
 <70/1.8ReferenceReference
 70/1.8–99/2.60.53 (0.31 to 0.92)1.15 (0.50 to 2.65)
 100/2.6–129/3.30.63 (0.37 to 1.10)1.16 (0.49 to 2.80)
 130/3.4–160/4.10.88 (0.48 to 1.60)1.26 (0.48 to 3.26)
 >160/4.11.12 (0.54 to 2.31)1.94 (0.66 to 5.75)
  • *Adjusting for age, gender, comorbidities, use of lipid-lowering medications and use of rheumatoid arthritis medications.

  • CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MI, myocardial infarction.